Search results
The stage (extent) of endometrial cancer is the most important factor in choosing treatment. But other factors can also affect your treatment options, including the type of cancer, your age and overall health, and whether you want to be able to have children.
This ESMO Clinical Practice Guideline provides key recommendations for managing endometrial cancer. The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment and management algorithms according to risk-groups and for advanced/metastatic or recurrent disease are provided.
11 sie 2023 · Endometrial cancer is usually first treated with surgery to remove the cancer. This may include removing the uterus, fallopian tubes and ovaries. Other treatment options may include radiation therapy or treatments using medicines to kill the cancer cells.
18 gru 2020 · Ovarian preservation can be considered in pre-menopausal patients aged <45 years with low-grade endometrioid endometrial carcinoma with myometrial invasion <50% and no obvious ovarian or other extra-uterine disease (IV, A). In cases of ovarian preservation, salpingectomy is recommended (IV, B).
8 cze 2022 · This ESMO Clinical Practice Guideline provides key recommendations for managing endometrial cancer. •. The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. •. Treatment and management algorithms according to risk groups and for advanced/metastatic or recurrent disease are provided. •.
13 lis 2020 · Endometrial cancer treatment often only requires surgery, but sometimes radiation, chemotherapy, and hormonal therapy may be needed. Learn more about the diagnosis, prognosis, and treatment for newly diagnosed and recurrent endometrial cancer in this expert-reviewed summary.
This review aims to present old, new and emerging perspectives in the management of endometrial cancer and evaluate the existing therapeutic strategies, by assessing the different surgical routes, the position of adjuvant therapies in the treatment of endometrial cancer and the implementation of SLNB.
